Inventor · disambiguated record
Eugene Medlock
Also filed as: MEDLOCK EUGENE
6 granted patents·12 pending applications·180 citations·filing 2001–2013
84Inventor score
Top patents by PatentIndex Score
18 records- 0196US7611857B2IL-receptor like molecules and uses thereofAMGEN INC·Filed 2005·Granted Nov 3, 2009·58 cites·9 claims
- 0295US7094566B2IL-17 receptor like molecules and uses thereofAMGEN INC·Filed 2001·Granted Aug 22, 2006·73 cites·26 claims
- 0392US7718776B2Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitorsAMGEN INC·Filed 2003·Granted May 18, 2010·47 cites·50 claims
- 0477US7943738B2IL-17 receptor like molecules and uses thereofAMGEN INC·Filed 2009·Granted May 17, 2011·2 cites·7 claims
- 0562US2014037635A1Methods of treatment using il-17e antagonistsAMGEN INC·Filed 2013·Application pending·0 cites
- 0661US2007123459A1IL-17 like molecules and uses thereofAMGEN INC·Filed 2006·Application pending·0 cites
- 0760US2013171168A1Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway InhibitorsAMGEN INC·Filed 2013·Application pending·0 cites
- 0860US2013164292A1Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway InhibitorsAMGEN INC·Filed 2012·Application pending·0 cites
- 0959US8455629B2Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitorsBOYLE WILLIAM J·Filed 2012·Granted Jun 4, 2013·0 cites·18 claims
- 1058US2005048029A1Il-17 like molecules and uses thereofAMGEN INC·Filed 2004·Application pending·0 cites
- 1157US2005074427A1IL-17 like molecules and uses thereofFiled 2004·Application pending·0 cites
- 1257US2005003451A1IL-17 like molecules and uses thereofFiled 2004·Application pending·0 cites
- 1356US8367063B2Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitorsAMGEN INC·Filed 2010·Granted Feb 5, 2013·0 cites·32 claims
- 1455US2011160438A1Il-17 receptor like molecules and uses thereofAMGEN INC·Filed 2010·Application pending·0 cites
- 1555US2010303820A1Methods of treatment using il-17e antagonistsAMGEN INC·Filed 2010·Application pending·0 cites
- 1653US2010209435A1Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway InhibitorsAMGEN INC·Filed 2010·Application pending·0 cites
- 1749US2003124092A1IL-17 like molecules and uses thereoflike molecules and uses thereofFiled 2001·Application pending·0 cites
- 1838US2002037524A1IL-17 like molecules and uses thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eugene Medlock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →